Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Mitragyna parvifolia
Tree of South and Southeast Asia related to kratom, used in Ayurveda and traditional Indian medicine.
Mitragyna parvifolia is a tree native to South and Southeast Asia, closely related to kratom, and has a history of use in Ayurveda and Indian folk medicine for fever, pain, diabetes, and rheumatism. Modern research suggests potential anti-inflammatory, antipyretic, antidiabetic, and blood pressure modulating effects, attributed to its alkaloids (mitraphylline, isorhynchophylline) and flavonoids. Evidence is primarily preliminary (Level C), with traditional use well-documented.
Mitraphylline and isorhynchophylline are thought to interact with opioid receptors (mu and delta), contributing to analgesic and sedative effects, while also modulating adrenergic and serotonergic pathways to influence blood pressure and inflammation. Flavonoids provide antioxidant and anti-inflammatory actions via inhibition of cyclooxygenase (COX) and lipoxygenase (LOX) enzymes. Antidiabetic effects may involve activation of AMPK and enhancement of insulin sensitivity, as suggested by in vitro and animal studies.
Tree of South and Southeast Asia related to kratom, used in Ayurveda and traditional Indian medicine.
Mitragyna parvifolia is a tree native to South and Southeast Asia, closely related to kratom, and has a history of use in Ayurveda and Indian folk medicine for fever, pain, diabetes, and rheumatism. Modern research suggests potential anti-inflammatory, antipyretic, antidiabetic, and blood pressure modulating effects, attributed to its alkaloids (mitraphylline, isorhynchophylline) and flavonoids. Evidence is primarily preliminary (Level C), with traditional use well-documented.
Mitraphylline and isorhynchophylline are thought to interact with opioid receptors (mu and delta), contributing to analgesic and sedative effects, while also modulating adrenergic and serotonergic pathways to influence blood pressure and inflammation. Flavonoids provide antioxidant and anti-inflammatory actions via inhibition of cyclooxygenase (COX) and lipoxygenase (LOX) enzymes. Antidiabetic effects may involve activation of AMPK and enhancement of insulin sensitivity, as suggested by in vitro and animal studies.